PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Bruno Sangro, MD, PhD - A New Era in the Management of Advanced HCC: Sequencing Therapies for the Second-Line and Beyond
Visit https://www.peervoice.com/CGZ860 to view the entire programme with slides. After completing “Bruno Sangro, MD, PhD - A New Era in the Management of Advanced HCC: Sequencing Therapies for the Second-Line and Beyond”, participants will be able to: Identify key decision points in the sequencing of therapies in advanced hepatocellular carcinoma (HCC) and patient assessments to guide transitions from first- to second-line treatment; Evaluate available data to guide the appropriate choice and sequencing of therapies in the second-line setting for advanced HCC and their use following first-line treatment strategies; and Use an informed approach when sequencing therapies for individual patients with advanced HCC based on available data, pharmacologic characteristics of approved therapies, and patient-specific factors.